Literature DB >> 29588764

Application in Hypertension of Renal Sympathetic Denervation - A Review.

Dominik Linz1, Felix Mahfoud1, Sebastian Ewen1, Stephan H Schirmer1, Jan Reil1, Christian Ukena1, Michael Böhm1.   

Abstract

Afferent and efferent sympathetic nerves of the kidney located in the adventitia of the renal artery are involved in the regulation of blood pressure and play a pathophysiological role in the progression and maintenance of hypertension. Renal sympathetic denervation is a potent and safe catheter-based therapeutic approach for the treatment of patients with resistant hypertension. Clinical trials of renal sympathetic denervation have shown significant reduction in blood pressure, which was associated with a reduction in local renal norepinephrine spillover as well as a reduction of whole body sympathetic activation in resistant hypertensive patients.

Entities:  

Keywords:  Renal sympathetic denervation; blood pressure; hypertension; sympathetic nervous system

Year:  2013        PMID: 29588764      PMCID: PMC5808477          DOI: 10.15420/icr.2013.8.2.124

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  18 in total

1.  Renal denervation in moderate to severe CKD.

Authors:  Dagmara Hering; Felix Mahfoud; Antony S Walton; Henry Krum; Gavin W Lambert; Elisabeth A Lambert; Paul A Sobotka; Michael Böhm; Bodo Cremers; Murray D Esler; Markus P Schlaich
Journal:  J Am Soc Nephrol       Date:  2012-05-17       Impact factor: 10.121

Review 2.  Functional role of renal afferents.

Authors:  A Stella; A Zanchetti
Journal:  Physiol Rev       Date:  1991-07       Impact factor: 37.312

Review 3.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

4.  Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.

Authors:  Felix Mahfoud; Thomas Felix Lüscher; Bert Andersson; Iris Baumgartner; Renata Cifkova; Carlo Dimario; Pieter Doevendans; Robert Fagard; Jean Fajadet; Michel Komajda; Thierry Lefèvre; Chaim Lotan; Horst Sievert; Massimo Volpe; Petr Widimsky; William Wijns; Bryan Williams; Stephan Windecker; Adam Witkowski; Thomas Zeller; Michael Böhm
Journal:  Eur Heart J       Date:  2013-04-25       Impact factor: 29.983

5.  Renal denervation in moderate treatment-resistant hypertension.

Authors:  Christian Ott; Felix Mahfoud; Axel Schmid; Tilmann Ditting; Paul A Sobotka; Roland Veelken; Aline Spies; Christian Ukena; Ulrich Laufs; Michael Uder; Michael Böhm; Roland E Schmieder
Journal:  J Am Coll Cardiol       Date:  2013-07-10       Impact factor: 24.094

Review 6.  The sympathetic nervous system in chronic kidney disease.

Authors:  Sebastian Ewen; Christian Ukena; Dominik Linz; Roland E Schmieder; Michael Böhm; Felix Mahfoud
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 7.  Response and non-response to renal denervation: who is the ideal candidate?

Authors:  Christian Ukena; Bodo Cremers; Sebastian Ewen; Michael Böhm; Felix Mahfoud
Journal:  EuroIntervention       Date:  2013-05       Impact factor: 6.534

8.  Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.

Authors:  Felix Mahfoud; Christian Ukena; Roland E Schmieder; Bodo Cremers; Lars C Rump; Oliver Vonend; Joachim Weil; Martin Schmidt; Uta C Hoppe; Thomas Zeller; Axel Bauer; Christian Ott; Erwin Blessing; Paul A Sobotka; Henry Krum; Markus Schlaich; Murray Esler; Michael Böhm
Journal:  Circulation       Date:  2013-06-18       Impact factor: 29.690

9.  Sympatho-renal axis in chronic disease.

Authors:  Paul A Sobotka; Felix Mahfoud; Markus P Schlaich; Uta C Hoppe; Michael Böhm; Henry Krum
Journal:  Clin Res Cardiol       Date:  2011-06-19       Impact factor: 5.460

10.  Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Authors:  Henry Krum; Markus Schlaich; Rob Whitbourn; Paul A Sobotka; Jerzy Sadowski; Krzysztof Bartus; Boguslaw Kapelak; Anthony Walton; Horst Sievert; Suku Thambar; William T Abraham; Murray Esler
Journal:  Lancet       Date:  2009-03-28       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.